ARB-002.M

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameARB-002.M

Drug Alias Nameanti-GPC3 bispecific monoclonal antibody (Arbele)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionGlypican-3 inhibitors

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArbele Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArbele Corp

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Other Information

ATC CodeN/A